Clinical Trial Update: Efficacy and Safety of Two Doses of HIL-214 in Children [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial evaluating two doses of HIL-214 in children with gastroenteritis has been terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteritis

Drugs mentioned

• HIL-214

Snippet

Sponsor: HilleVax | Conditions: Gastroenteritis | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2025-07-10